Versions Compared
compared with
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Cancer Synoptic Reporting Project Group
5
21 April at
1716:00 - 18:30 UTC
Attendees
@Apologies
Discussion items
Item | Description | Owner | Notes | Action | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Conflict of Interest | ||||||||||||
2Project updates | Concepts promoted to task and in queue for promotion |
| |||||||||||
3 | Concepts in review for inclusion in task | Scott Campbell |
|
| |||||||||
4 | 3 | Lymph-vascular body structure | Review/discuss body structure concept for lymph vessel and/or small blood vessel body structure | 4 | Method used to "grade" or "stage" | Review/discuss general observable for "Method used to..." | 5 | Grade finding (finding) | Scott Campbell | Discuss clinical finding concepts in existing SI content. To inactivate or not - Follow up with UK use case |
| ||
5 | Next concepts |
|
| ||||||||||
6 | Business meeting | I&E documents to do and review | Cancer Synoptic Reporting | ||||||||||
7 | Histology discussion | Removal of 86049000 |Malignant neoplasm, primary (morphologic abnormality)| and similar high-level concepts. Challenge for this group and disorders. Removal of concepts like: 2092003 |Malignant melanoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)| |
Note: primary/secondary/metastatic/unknown/post-treatment tumors discussion needs to move back to editorial advisory group. FSN implications and definitions....more discussion needed. How does this impact grouper concepts |
Meeting Files
Attachments |
---|
Previous Meetings
Content Report Table | ||||||||
---|---|---|---|---|---|---|---|---|
|